Skip to main content

Table 1 Prevalence of the antibody response in 681 individuals infected with Plasmodium vivax

From: Humoral and cellular immune response to Plasmodium vivax VIR recombinant and synthetic antigens in individuals naturally exposed to P. vivax in the Republic of Korea

Recombinant protein or synthetic peptides Prevalence of positive sera (%)
IgG (nā€‰=ā€‰681) IgM (nā€‰=ā€‰681)
VIR-A4 91 (13.4) 123 (18.1)
VIR-B10 103 (15.1) 116 (17.0)
VIR-C1 123 (18.1) 113 (16.6)
VIR-C2 157 (23.1) 146 (21.4)
VIR25 189 (27.8) 199 (29.2)
VIR14 82 (12.0) 56 (8.2)
VIR2 45 (6.6) 43 (6.3)
PvLP1 71 (10.4) 58 (8.5)
PvLP2 79 (11.6) 89 (13.1)
MSP1-19 621 (91.2) ND